Aleš ŠtrancarCEO at BIA Separations, Slovenia
Ales Štrancar is the CEO of BIA Separations d.o.o. and one of the main inventors of the CIM Convective Interaction Media® monolithic columns (new generation of chromatographic support).
After finishing MSc at University of Ljubljana he headed the parent company BIA d.o.o. for 8 years. During this time BIA d.o.o. was profitable and reached the growth in turn over from 13K EUR in 1991 (3 employees) to 1.275K EUR in 1998 (15 employees). Beside the main activity, selling and servicing pharma lab equipment, BIA d.o.o. was active in R&D. In 1998 the CIM project got a venture capital investment and new company BIA Separations d.o.o. was funded to further develop CIM and is headed by Štrancar since then.
In parallel to running BIA d.o.o. Štrancar was PhD student with 30% of his time working in company Octapharma, Vienna to develop purification processes of plasma proteins using monolithic supports.
Štrancar is author or co-author of more than 90 scientific papers dealing with separation and purification technologies. He is a co-author of 5 granted USA patents and their foreign equivalents, more pending, in the field of biomolecule separations and purification. As well he is a co-author of several book chapters dealing with novel chromatography technologies for biomolecule separation.
He co-developed a number of industrial scale purification processes, among them for Octapharma, Vienna, for Boehringer Ingelheim, Vienna and for AveXis, now Novartis.
Ales Strancar served as Assistant Professor at Biotechnical Faculty of University of Ljubljana for 8 years.